PAR 4.84% 29.5¢ paradigm biopharmaceuticals limited..

FiftyOne Capital, page-38

  1. 249 Posts.
    lightbulb Created with Sketch. 20
    of interest to par holders??

    Global Pentosan Polysulfate Sodium Market Outlook 2016-2021

    Lowest Prices GuaranteedLengthPublisherPublished DateSKU
    1from $6,00093 PagesGen Consulting Company July, 2016 GCC15082666

    The global pentosan polysulfate sodium market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global pentosan polysulfate sodium market are Janssen Pharmaceutical, Bene Pharmachem, Cf Pharma, Alembic, Parabolic Drugs, etc.
    Pentosan Polysulfate Sodium production, which measures output worldwide, was expected to reach 10,031 kg in 2016 with an increase of 7.51% from its year-earlier level. The global pentosan polysulfate sodium market size is estimated to grow from USD 42.34 million in 2011 to USD 54.59 million by 2016, at an estimated CAGR of 5.21% between 2011 and 2016. With regards to this, key players of pentosan polysulfate sodium industry are expected to find potential opportunities in this market.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $86.19K 286.7K

Buyers (Bids)

No. Vol. Price($)
4 70151 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 18600 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.